{"nct_id":"NCT01926782","title":"Study to Evaluate the Efficacy and Safety of an Every Four Weeks Treatment Regimen of Alirocumab (REGN727/ SAR236553) in Patients With Primary Hypercholesterolemia (ODYSSEY CHOICE 1)","status":"COMPLETED","status_verified_date":"2017-01","start_date":"2013-09","start_date_type":null,"primary_completion_date":"2014-09","primary_completion_date_type":"ACTUAL","completion_date":"2015-04","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["REGN"]}